← Back to Patent Explorer
US4083972A Expired / Lapsed US ⏱️ 0.0 years remaining

Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue

Assignee: Procter and Gamble Co
•
Filing: 1976-08-16
•
Granted: 1978-04-11
•
Expires: 1996-08-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compositions for inhibiting anomalous deposition and mobilization of calcium phosphates in animal tissue, comprising an effective amount of an alkali metal, ammonium or substituted ammonium carbonyldiphosphonate in a pharmaceutical carrier; and a method for treating conditions involving pathological calcification and hard tissue demineralization in an animal comprising administering to such animal said compositions.

Inventors

  • 👤 Marion David Francis

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 01:39
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/66; A23; A23K; A23K20/00; A23K20/10; A23K20/105

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 31 words
A method for treating urolithiasis comprising administering to an animal afflicted therewith an effective but non-toxic amount of a pharmaceutically acceptable alkali metal, ammonium, or low molecular weight substituted ammonium carbonyldiphosphonate.
Claim 2
Independent Claim 31 words
A method for treating urolithiasis comprising administering to an animal afflicted therewith an effective but non-toxic amount of a pharmaceutically acceptable alkali metal, ammonium, or low molecular weight substituted ammonium carbonyldiphosphonate.
Claim 3
Independent Claim 31 words
A method for treating arteriosclerosis comprising administering to an animal afflicted therewith an effective but non-toxic amount of a pharmaceutically acceptable alkali metal, ammonium, or low molecular weight substituted ammonium carbonyldiphosphonate.
Claim 4
Independent Claim 31 words
A method for treating arteriosclerosis comprising administering to an animal afflicted therewith an effective but non-toxic amount of a pharmaceutically acceptable alkali metal, ammonium, or low molecular weight substituted ammonium carbonyldiphosphonate.

References Cited (Backward Citations)

US3488419A Cited
US3536628A Cited
US3497313A Cited
US3560608A Cited
US3641246A Cited
US3662066A Cited
US3719756A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-04-10 1981-10-10 1982-04-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-04-10 1985-10-10 1986-04-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-04-10 1989-10-10 1990-04-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag